Skip to content
ppharmaranks
Menu
Class IOngoing

Cyclophosphamide for Injection recall

FDA recall D-0743-2026 · initiated Jul 17, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Aug 12, 2026How we research

Sunny Pharmtech Inc. recalled Cyclophosphamide for Injection in Jul 2026 — an FDA Class I recall (D-0743-2026) because Presence of Particulate Matter; identified as stainless steel.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Presence of Particulate Matter; identified as stainless steel

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # C23019V1, Exp 10/31/2026; C24015V1, Exp 4/30/2027

Quantity recalled: 4,077 vials

Details

Product
Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1
Recalling company
Sunny Pharmtech Inc.
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
USA Nationwide
Initiated
Jul 17, 2026
FDA report date
Aug 12, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Cyclophosphamide for Injection recalled?
Sunny Pharmtech Inc. recalled Cyclophosphamide for Injection in Jul 2026 — an FDA Class I recall (D-0743-2026) because Presence of Particulate Matter; identified as stainless steel. Most serious — a reasonable probability that use will cause serious harm or death.
Why was Cyclophosphamide for Injection recalled?
Per the FDA enforcement record, the reason for recall D-0743-2026 was: Presence of Particulate Matter; identified as stainless steel
Is a recalled Cyclophosphamide for Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Cyclophosphamide for Injection are affected?
Distributed: USA Nationwide. The recall covers these lots — Lot # C23019V1, Exp 10/31/2026; C24015V1, Exp 4/30/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0743-2026.

Source: openFDA Drug Enforcement record D-0743-2026

← All drug recalls